PR Date $ACAD PR Date $NEU Topic 1 12/09/2022 13/09/2022 NDA Filing & PDUFA Date at 12/03/2023 2 18/06/2022 19/07/2022 (!) NDA Filing 3 06/12/2021 07/12/2021 Topline Results P3 Lavender 4 - 01/09/2021 Announcing start Dafodil trials(Girls 2-5) 5 - 05/08/2021 P3 successfully enrollment completion 6 03/032020 04/03/2020 Rare Pediatric Trial Designation 7 30/10/2019 31/10/2019 Initiation of Ph 3 Trial 8 27/03/2019 28/03/2019 Positive Ph 2 Trial Results published 9 06/08/2018 07/08/2018 Exclusive USA Deal with Acadia announced
So, as could be expected, all results relating to FDA comes first from $ACAD followed by $NEU... I'll be looking for $ACAD PR (probably after market closes)..
Ann: Rett Syndrome NDA accepted for Priority Review by FDA, page-64
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$12.54 |
Change
0.100(0.80%) |
Mkt cap ! $1.559B | |||
| Open | High | Low | Value | Volume |
| $12.44 | $12.73 | $12.13 | $11.07M | 885.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1215 | $12.52 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.54 | 804 | 1 |
View Market Depth
| Last trade - 16.10pm 20/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |